NOV 9-11, 2017
NOV 9-11, 2017
/
Orlando, Florida
Orlando, Florida
/
Walt Disney World Dolphin Hotel
Walt Disney World Dolphin Hotel
Register Now
BY FAR, THE BEST IBD CONFERENCE AROUND!
-AIBD CONFERENCE ATTENDEE
Register Now

Cultural options in Orlando offer a mix

of traditional and modern entertainment for visitors.

Cultural options in Orlando offer a mix

of traditional and modern entertainment for visitors.

COME ENJOY ALL ORLANDO HAS TO OFFER!
COME ENJOY ALL ORLANDO HAS TO OFFER!
NOV 9-11, 2017
/
Orlando, Florida
/
Walt Disney World Dolphin Hotel
Register Now

NEW PRESENTERS, NEW CONTENT, A NEW YEAR

Orlando, Florida, November 9-11

The management of IBD is rapidly evolving. In terms of practice guidelines, choice of therapy, and diagnostic and surgical techniques, never before have so many options been available for use in clinical practice. As such, healthcare professionals like yourself need opportunities to learn about, reinforce, and share their experiences with the latest, most important, and clinically-relevant data and practices that directly impact patient care.

Held on November 9-11, 2017 in Orlando, Florida, the 2017 Advances in Inflammatory Bowel Diseases is designed to be the premiere event that meets the growing educational needs of healthcare professionals and researchers who study and manage patients with inflammatory bowel diseases.

Over the course of three intensive days, clinicians will gain practice-changing knowledge which can be implemented immediately, researchers will stay abreast of the evolving scientific landscape, nurses and allied healthcare providers will develop and share best practices in multidisciplinary care, and surgeons will observe and gain insight into the latest advances and techniques.

From education to networking, AIBD 2017 provides everything you need to improve the care of your patients and advance your career in the field.

Have questions? We can help. Please email us at registration@imedex.com or call us at +1 (800) 233-0957

TIMELINE

Important Dates:

September 21:
Early Registration Deadline

October 26:
Discounted Registration Deadline

ENDORSED BY

MEDIA PARTNER


The Official Media Partner of the Advances in Inflammatory Bowel Diseases Conference

CHAIRS

Richard P. MacDermott, MD, MACG

Emeritus Professor of Medicine
Albany Medical Center
Albany, New York

Stephen B. Hanauer, MD, FACG

Northwestern University
Feinberg School of Medicine
Chicago, Illinois

Miguel D. Regueiro, MD, FACG

University of Pittsburgh
School of Medicine
Pittsburgh, Pennsylvania
Day 1
Nov 09 2017
Day 2
Nov 10 2017
Day 3
Nov 11 2017

CLINICAL TRACK
Session I-A: The Multidisciplinary, Patient Centered Approach to IBD Care

Co-Moderators: Raymond K. Cross, Jr., MD, MS and Sunanda V. Kane, MD, MSPH, FACG

11:55 am

Welcome and introduction to Day 1
Stephen B. Hanauer, MD, FACG, Richard P. MacDermott, MD, MACG, and Miguel D. Regueiro, MD, FACG

12:00 pm

Rationale for a multidisciplinary, patient-centered approach to IBD care
Stephen B. Hanauer, MD, FACG and Corey A. Siegel, MD, MS

12:20 pm

Management of psycho-social issues for IBD patients and their families
Laurie A. Keefer, PhD and Eva Szigethy, MD, PhD, FACG

12:40 pm

The multidisciplinary surgical approach to IBD patient care
Amy L. Lightner, MD and Scott A. Strong, MD

1:00 pm

The pediatric-adult transition: How to bridge the change
Sandra C. Kim, MD and Millie D. Long, MD, MPH

1:20 pm

Novel approaches to improve caregiver-patient interactions using integrated models
Gil Y. Melmed, MD, FACG and Miguel D. Regueiro, MD, FACG

1:40 pm

Panel discussion

2:00 pm

Break

Raymond K. Cross, Jr., MD, MS
Stephen B. Hanauer, MD, FACG
Sunanda V. Kane, MD, MSPH, FACG
Laurie A. Keefer, PhD
Sandra C. Kim, MD
Amy L. Lightner, MD
Millie D. Long, MD, MPH, FACG
Richard P. MacDermott, MD, MACG
Gil Y. Melmed, MD, FACG
Miguel D. Regueiro, MD, FACG
Corey A. Siegel, MD, MS
Scott Strong, MD
Eva Szigethy, MD, PhD, FACG

CLINICAL TRACK
Session II-A: The Changing Healthcare Landscape

Co-Moderators: Jean-Federic Colombel, MD and Stephen B. Hanauer, MD, FACG

2:30 pm

Will changes in healthcare legislation impact IBD patient care?
John I. Allen, MD, MBA, FACG

2:50 pm

How can the caregiver better navigate medication choice and cost hurdles?
Shivani Patel, PharmD, BCPS and David T. Rubin, MD, FACG

3:10 pm

What should medical centers and administrators do in order to optimize patient care in our complex environment
John I. Allen, MD, MBA, FACG and Thomas A. Ullman, MD, FACG

3:30 pm

Advances in information technology that will improve patient care: Electronic medical records, the internet, social media, telemedicine, and remote video-medicine
Raymond K. Cross, Jr., MD, MS and Siddharth Singh, MD, MBBS, MS

3:50 pm

What we can learn from the European Crohn's and Colitis Organization's approaches to IBD Education and IBD Guidelines
Silvio Danese, MD, PhD

4:10 pm

Panel discussion

4:40 pm

Break

John I. Allen, MD, MBA, FACG
Jean-Frederic Colombel, MD
Raymond K. Cross, Jr., MD, MS
Silvio Danese, MD, PhD
Stephen B. Hanauer, MD, FACG
Shivani Patel, PharmD
David T. Rubin, MD, FACG
Siddharth Singh, MD, MBBS, MS
Thomas A. Ullman, MD, FACG

CLINICAL TRACK
Session III-A: New and Emerging Therapeutic Approaches for IBD

Co-Moderators: David T. Rubin, MD, FACG and Bruce E. Sands, MD, MS, FACG

5:10 pm

The treatment of moderate to severe IBD with anti-TNF Biologics and Immunomodulators
Gary R. Lichtenstein, MD, FACG

5:30 pm

Optimizing adhesion molecule-based therapies
Brian G. Feagan, MD, FACG

5:50 pm

Understanding the use of IL12/IL23 targeted Biologics
William J. Sandborn, MD, FACG

6:10 pm

Future IBD therapies
Silvio Danese, MD, PhD

6:30 pm

Panel discussion

7:00 pm

Adjourn and Reception

Silvio Danese, MD, PhD
Brian G. Feagan, MD, FACG
Gary R. Lichtenstein, MD, FACG
David T. Rubin, MD, FACG
William J. Sandborn, MD, FACG
Bruce E. Sands, MD, MS, FACG

NURSING & ADVANCED PRACTICE TRACK
Session IV-B: Multidisciplinary IBD Patient Management

Co-Moderators: Maureen Kelly, APN, MS, PNP and Michele Rubin, MSN, APN, CNS, CGRN

7:55 am

Welcome and Introduction
Michele Rubin, MSN, APN, CNS, CGRN

8:00 am

10 things every IBD nurse should know
Ashley A. Bochenek, AA, BSN, MSN

8:30 am

The nurse's role in multidisciplinary "treat to target" patient care
Anne Bobb, BSN, RN

9:00 am

Child and parental coping strategies
Maureen Kelly, APN, MS, PNP

9:30 am

J-Pouch assessment, management, and surveillance: Strategies by a multidisciplinary team
Michele Rubin, MSN, APN, CNS, CGRN

10:00 am

Break

Anne Bobb, BSN, RN
Ashley A. Bochenek, AA, BSN, MSN
Maureen Kelly, APN, MS, PNP
Michele Rubin, MSN, APN, CNS, CGRN

CLINICAL TRACK
Session IV-A: Making the Choice of Therapy for Crohn’s Disease: How Evidence Impacts Practice

Co-Moderators: Nilesh Chande, MD and Miguel D. Regueiro, MD, FACG

7:55 am

Welcome and introduction to Day 2
Stephen B. Hanauer, MD, FACG, Richard P. MacDermott, MD, MACG, and Miguel D. Regueiro, MD, FACG

8:00 am

Presentation on Cochrane Reviews
Nilesh Chande, MD

8:10 am

Presentation #1: Use of anti-TNF therapies for Crohn's disease
Siddharth Singh, MD, MBBS, MS

8:30 am

Presentation #1: Cases with debate and discussion
Panelists: Brian G. Feagan, MD, FACG, Stephen B. Hanauer, MD, FACG, William J. Sandborn, MD, FACG, and Siddharth Singh, MD, MBBS, MS

8:40 am

Presentation #2: Vedolizumab as a treatment for Crohn’s Disease: Efficacy and safety
William J. Sandborn, MD, FACG

9:00 am

Presentation #2: Cases with debate and discussion
Panelists: Brian G. Feagan, MD, FACG, Stephen B. Hanauer, MD, FACG, William J. Sandborn, MD, FACG, and Siddharth Singh, MD, MBBS, MS

9:10 am

Presentation #3: Ustekinumab as a treatment for Crohn’s disease: Efficacy and safety
Brian G. Feagan, MD, FACG

9:30 am

Presentation #3: Cases with debate and discussion
Panelists: Brian G. Feagan, MD, FACG, Stephen B. Hanauer, MD, FACG, William J. Sandborn, MD, FACG, and Siddharth Singh, MD, MBBS, MS

9:40 am

Concluding remarks and Q&A period

10:00 am

Break

Nilesh Chande, MD
Brian G. Feagan, MD, FACG
Stephen B. Hanauer, MD, FACG
Richard P. MacDermott, MD, MACG
Miguel D. Regueiro, MD, FACG
William J. Sandborn, MD, FACG
Siddharth Singh, MD, MBBS, MS

NURSING & ADVANCED PRACTICE TRACK
Session V-B: Case Presentations and Interactive Discussion

Co-Moderators: Maureen Kelly, APN, MSN, PNP and Michele Rubin, MSN, APN, CNS, CGRN

10:30 am

Joint pains: Are they IBD or arthritis related?
Ashley A. Bochenek, AA, BSN, MSN

11:00 am

"Helicopter parents": How to manage using a multidisciplinary team
Pamela J. Morgan, BSN, RN

11:30 am

Risk and benefits of cannibis for IBD patients
Betty J. White, MN, NP-C, ARNP

12:00 pm

Adjusting to a new ostomy and managing stoma complications
Michele Rubin, MSN, APN, CNS, CGRN

12:30 pm

Lunch and Satellite Symposia

Ashley A. Bochenek, AA, BSN, MSN
Maureen Kelly, APN, MS, PNP
Pamela J. Morgan, BSN, RN
Michele Rubin, MSN, APN, CNS, CGRN
Betty J. White, MN, NP-C, ARNP

CLINICAL TRACK
Session V-A: Case Discussions in IBD

Co-Moderators: Miguel D. Regueiro, MD, FACG and Corey A. Siegel, MD, MS

10:30 am

Case Discussion I: Management of infections in IBD patients on immunomodulators and/or biologics
Panelists: David G. Binion, MD, FACG, Russell D. Cohen, MD, FACG, Jean-Frederic Colombel, MD, and Edward V. Loftus, Jr., MD, FACG

11:00 am

Case Discussion II: Challenges in the care of the pregnant IBD patient
Panelists: Maria T. Abreu, MD, Kim L. Isaacs, MD, PhD, FACG, and Sunanda V. Kane, MD, MSPH, FACG

11:30 am

Case Discussion III: When and how to modify IBD therapies: Increasing, maintaining or de-escalating biologics and/or immunomodulators; Future use of combination biologics
Panelists: Gary R. Lichtenstein, MD, FACG, David T. Rubin, MD, FACG, William J. Sandborn, MD, FACG, and Bruce E. Sands, MD, MS, FACG

12:00 pm

Case Discussion IV: Controversies in the surgical management of complicated Crohn's disease
Panelists: Andre D'Hoore, MD, PhD, Philip Fleshner, MD, and Feza Remzi, MD

12:30 pm

Lunch and satellite symposia

Maria T. Abreu, MD
David G. Binion, MD, FACG
Russell D. Cohen, MD, FACG
Jean-Frederic Colombel, MD
Andre D’Hoore, MD, PhD
Phillip Fleshner, MD
Kim L. Isaacs, MD, PhD, FACG
Sunanda V. Kane, MD, MSPH, FACG
Gary R. Lichtenstein, MD, FACG
Edward V. Loftus, Jr., MD, FACG
Miguel D. Regueiro, MD, FACG
Feza Remzi, MD
David T. Rubin, MD, FACG
William J. Sandborn, MD, FACG
Bruce E. Sands, MD, MS, FACG
Corey A. Siegel, MD, MS

CLINICAL TRACK
Session VI-A: Case-based Clinical Breakout Session

2:00 pm

A: The outpatient with severe, refractory Crohn's disease, who failed prior biologics: Case studies
Ashwin N. Ananthakrishnan, MBBS, MD, MPH, Jean H. Ashburn, MD, Gary R. Lichtenstein, MD, FACG, and Fernando S. Velayos, MD, MPH

B. Extra-intestinal manifestations of IBD: Case studies
Anita Afzali, MD, MPH, FACG, Meenaskshi Bewtra, MD, PhD, MPH, Russell D. Cohen, MD, FACG, and Marc B. Schwartz, MD

C. Challenges in the surgical management of severe, refractory ulcerative colitis: Case studies with videos
David Dietz, MD, Neil H. Hyman, MD, Sonia Ramamoorthy, MD, FACS, FASCRS, and Douglas C. Wolf, MD, FACG

D. Sexual Dysfunction in IBD: Case studies
Raymond K. Cross, Jr., MD, MS, Marla Dubinsky, MD, Andre D'Hoore, MD, PhD, and Kim L. Isaacs, MD, PhD, FACG

E. Treating IBD patients with stress, anxiety, and/or depression: Case studies
Laurie A. Keefer, PhD, Alan C. Moss, MD, FACG, Mark T. Osterman, MD, MSCE, and Eva Szigethy, MD, PhD, FACG

F. When should the asymptomatic or mildly symptomatic IBD patient be treated? Case studies
Faten N. Aberra, MD, MSCE, Maria T. Abreu, MD, L. Campbell Levy, MD, and Thomas A. Ullman, MD, FACG

2:45 pm

Case-based sessions end: Participants have 15 minutes to move to new session

3:00 pm

A: The outpatient with severe, refractory Crohn's disease, who failed prior biologics: Case studies
Ashwin N. Ananthakrishnan, MBBS, MD, MPH, Jean H. Ashburn, MD, Gary R. Lichtenstein, MD, FACG, and Fernando S. Velayos, MD, MPH

B. Extra-intestinal manifestations of IBD: Case studies
Anita Afzali, MD, MPH, FACG, Meenaskshi Bewtra, MD, PhD, MPH, Russell D. Cohen, MD, FACG, and Marc B. Schwartz, MD

C. Challenges in the surgical management of severe, refractory ulcerative colitis: Case studies with videos
David Dietz, MD, Neil H. Hyman, MD, Sonia Ramamoorthy, MD, FACS, FASCRS, and Douglas C. Wolf, MD, FACG

D. Sexual Dysfunction in IBD: Case studies
Raymond K. Cross, Jr., MD, MS, Marla Dubinsky, MD, Andre D'Hoore, MD, PhD, and Kim L. Isaacs, MD, PhD, FACG

E. Treating IBD patients with stress, anxiety, and/or depression: Case studies
Laurie A. Keefer, PhD, Alan C. Moss, MD, FACG, Mark T. Osterman, MD, MSCE, and Eva Szigethy, MD, PhD, FACG

F. When should the asymptomatic or mildly symptomatic IBD patient be treated? Case studies
Faten N. Aberra, MD, MSCE, Maria T. Abreu, MD, L. Campbell Levy, MD, and Thomas A. Ullman, MD, FACG

3:45 pm

Break

Faten N. Aberra, MD, MSCE
Maria T. Abreu, MD
Anita Afzali, MD, MPH, FACG
Ashwin N. Ananthakrishnan, MBBS, MD, MPH
Jean H. Ashburn, MD
Meenakshi Bewtra, MD, PhD, MPH
Russell D. Cohen, MD, FACG
Raymond K. Cross, Jr., MD, MS
David Dietz, MD
Marla Dubinsky, MD
Andre D’Hoore, MD, PhD
Neil H. Hyman, MD
Kim L. Isaacs, MD, PhD, FACG
Laurie A. Keefer, PhD
L. Campbell Levy, MD
Gary R. Lichtenstein, MD, FACG
Alan C. Moss, MD, FACG
Mark T. Osterman, MD, MSCE
Sonia Ramamoorthy, MD, FACS, FASCRS
Marc B. Schwartz, MD
Eva Szigethy, MD, PhD, FACG
Thomas A. Ullman, MD, FACG
Fernando S. Velayos, MD, MPH
Douglas C. Wolf, MD, FACG

PEDIATRIC TRACK
Session VII-C: Progress in Pediatric IBD

Moderators: Sandra C. Kim, MD and Daniel von Allmen, MD

4:15 pm

Welcome and Introduction
Sandra C. Kim, MD and Daniel von Allmen, MD

4:25 pm

Pediatric IBD clinical year in review
Anne Griffiths, MD

4:45 pm

Advances in the use of nutrition for therapy in pediatric Crohn's disease
David Suskind, MD

5:05 pm

What are the challenges we face for pediatric patients who need surgery?
Daniel von Allmen, MD

5:25 pm

Case discussion: Challenges of self-image, sexuality; contraception and pregnancy in adolescents with IBD
Panelists: Marla Dubinsky, MD, Anne Griffiths, MD, and Sandra C. Kim, MD

5:55 pm

Panel discussion: Complex Pediatric IBD Cases

Case 1: Management of the hospitalized UC patient (Items to address include infectious sequelae- C. difficile; CMV; Medication dosing with high dose infliximab; Surgical timing)

Case 2: Management of the patient with complicated Crohn's disease

Moderators: Marla Dubinsky, MD and Sandra C. Kim, MD
Panel: Anne Griffiths, MD, David Suskind, MD, and Daniel von Allmen, MD

6:35 pm

Adjourn and reception

Marla Dubinsky, MD
Anne Griffiths, MD
Kim L. Isaacs, MD, PhD, FACG
David Suskind, MD
Daniel von Allmen, MD

CLINICAL TRACK
Session VII-A: Deciphering an IBD Operative Report: What Every Gastroenterologist Should Know

Co-Moderators: Philip R. Fleshner, MD, Amy L. Lightner, MD, Edward V. Loftus, Jr., MD, FACG, Gil Y. Melmed, MD, FACG, and Feza H. Remzi, MD

4:20 pm

Small bowel resection/stricturoplasty
Javier P. Salgado, MD

4:40 pm

Ileocolic resection
Neil Hyman, MD

5:00 pm

Ileal pouch-anal anastomosis
Philip R. Fleshner, MD

5:20 pm

Failing ileal J pouch
Feza H. Remzi, MD

5:40 pm

Perianal abscess and fistula
Amy L. Lightner, MD

6:00 pm

Panel discussion

Phillip Fleshner, MD
Neil H. Hyman, MD
Amy L. Lightner, MD
Edward V. Loftus, Jr., MD, FACG
Gil Y. Melmed, MD, FACG
Feza Remzi, MD
Javier P. Salgado, MD

CLINICAL TRACK
Session VIII-A: Advances in Endoscopy for IBD

Co-Moderators: Adam S. Cheifetz, MD, FACG and Douglas C. Wolf, MD, FACG

7:55 am

Welcome and introduction to Day 3
Stephen B. Hanauer, MD, FACG, Richard P. MacDermott, MD, MACG, and Miguel D. Regueiro, MD, FACG

8:00 am

Use of endoscopy to evaluate esophageal, gastric, and duodenal Crohn’s disease (videos)
Mark T. Osterman, MD, MSCE

8:20 am

How to access and determine the severity and complications of small bowel Crohn’s disease (videos)
Asher Kornbluth, MD

8:40 am

Using endoscopy to assess mucosal healing in “Treating to Target” for IBD (videos)
Francis A. Farraye, MD, MSc, FACG

9:00 am

Diagnosis and management of dysplasia and polyps in chronic ulcerative colitis (videos)
Fernando S. Velayos, MD, MPH

9:20 am

Modalities used to evaluate the differential diagnosis of refractory pouchitis (videos)
Bo Shen, MD, FACG

9:40 am

Panel discussion

10:00 am

Break

Adam S. Cheifetz, MD, FACG
Francis A. Farraye, MD, MSc, FACG
Stephen B. Hanauer, MD, FACG
Asher Kornbluth, MD
Richard P. MacDermott, MD, MACG
Mark T. Osterman, MD, MSCE
Miguel D. Regueiro, MD, FACG
Bo Shen, MD, FACG
Fernando S. Velayos, MD, MPH
Douglas C. Wolf, MD, FACG

SURGICAL TRACK
Session VIII-D: Debates in IBD Surgery

Co-Moderators: Paulo G. Kotze, MD and Sonia Ramamoorthy, MD, FACS, FASCRS

7:55 am

Welcome and introduction
Phillip R. Fleshner, MD, Amy L. Lightner, MD, and Feza Remzi, MD

8:00 am

Debate 1: The best technique for ileal pouch surgery: Top to bottom vs. Bottom to top

Pro: Top to bottom is the best technique for ileal pouch surgery
Neil Hyman, MD

Con: Bottom to top is the best technique for ileal pouch surgery
Andre D'Hoore, MD, PhD

8:30 am

Discussion, synthesis, and consensus

8:40 am

Debate 2: The best permanent stoma in IBD patients: End vs. Continent ileostomy

Pro: End ileostomy is the best permanent stoma in IBD patients
Javier P. Salgado, MD

Con: Continent ileostomy is the best permanent stoma in IBD patients
David Dietz, MD

9:10 am

Discussion, synthesis, and consensus

9:20 am

Debate 3: Do biologics heal anal fistulas? Definitely vs. Absolutely not

Pro: Biologics definitely heal anal fistulas
Paulo G. Kotze, MD

Con: Biologics absolutely do not heal anal fistulas
Willem Bemelman, MD

9:50 am

Discussion, synthesis, and consensus

10:00 am

Break

Willem Bemelman, MD
David Dietz, MD
Andre D’Hoore, MD, PhD
Phillip Fleshner, MD
Neil H. Hyman, MD
Paulo G. Kotze, MD
Amy L. Lightner, MD
Sonia Ramamoorthy, MD, FACS, FASCRS
Feza Remzi, MD
Javier P. Salgado, MD

CLINICAL TRACK
Session IX-A: Patient-related Factors Affecting IBD Management

Co-Moderators: Russell Cohen, MD, FACG and Asher Kornbluth, MD

10:30 am

Caring for the patient with multiple co-morbidities
Millie D. Long, MD, MPH, FACG and Alan C. Moss, MD, FACG

10:50 am

The use of complementary and alternative medications
Adam S. Cheifetz, MD, FACG and Andrew Tinsley, MD

11:10 am

Overlooked issues that will optimize the health of our patients
Gil Y. Melmed, MD, FACG and Corey A. Siegel, MD, MS

11:30 am

Prevention and management of side effects of therapies during pregnancy and postpartum
Sunanda V. Kane, MD, MSPH, FACG

11:50 am

How to treat chronic pain and avoid narcotic dependence
Laurie A. Keefer, PhD and Eva Szigethy, MD, PhD, FACG

12:10 pm

Panel discussion

12:30 pm

Lunch break and satellite symposia

Adam S. Cheifetz, MD, FACG
Russell D. Cohen, MD, FACG
Sunanda V. Kane, MD, MSPH, FACG
Laurie A. Keefer, PhD
Asher Kornbluth, MD
Millie D. Long, MD, MPH, FACG
Gil Y. Melmed, MD, FACG
Alan C. Moss, MD, FACG
Corey A. Siegel, MD, MS
Eva Szigethy, MD, PhD, FACG
Andrew Tinsley, MD

SURGICAL TRACK
Session IX-D: Challenges in IBD Surgery

Co-Moderators: David Dietz, MD, Javier P. Salgado, MD, and Daniel von Allmen, MD

10:30 am

When should a mucosectomy IPAA be done instead of a stapled IPAA?
Feza Remzi, MD

10:50 am

How to optimally use robotics in IBD surgery
Sonia Ramamoorthy, MD, FACS, FASCRS

11:10 am

Can stem cell therapy treat Crohn's disease fistulae?
Amy L. Lightner, MD

11:30 am

Does the choice of surgical technique impact recurrence rates following ileocolic resection for Crohn's disease?
Philiip Fleshner, MD

11:50 am

What sphincter preserving operations can be performed in patients with large bowel Crohn's disease?
Scott Strong, MD

12:10 pm

Panel discussion

12:50 pm

Lunch break

David Dietz, MD
Phillip Fleshner, MD
Amy L. Lightner, MD
Sonia Ramamoorthy, MD, FACS, FASCRS
Feza Remzi, MD
Javier P. Salgado, MD
Scott Strong, MD
Daniel von Allmen, MD

CLINICAL TRACK
Session X-A: Case-based Clinical Breakout Sessions

2:00 pm

A. Challenging IBD patients with concurrent liver disease: Case studies
Faten N. Aberra, MD, MSCE, David P. Hudesman, MD, Edward V. Loftus, Jr., MD, FACG, and Andrew Tinsley, MD

B. Treatment of complicated ulcerative colitis patients following surgery: Case studies with videos
Willem Bemelman, MD, Paulo G. Kotze, MD, Scott Strong, MD, and Thomas A. Ullman, MD, FACG

C. Managing IBD patients with a prior or current malignancy: Case Studies
Jean H. Ashburn, MD, Meenakshi Bewtra, MD, PhD, MPH, Jason K. Hou, MD, MS, FACG, and Lauren K. Tormey, MD

D. Recognizing and managing side effects due to medications used to treat IBD: Case studies
Anita Afzali, MD, MPH, FACG, Leonard Baidoo, MD, FACG, L. Campbell Levy, MD, and Millie D. Long, MD, MPH, FACG

E. Reassessing immunomodulators: Which patient, which drug, and which dose: Case studies
Ashwin N. Ananthakrishnan, MBBS, MD, MPH, Seymour Katz, MD, MACG, Marc B. Schwartz, MD, and Douglas C. Wolf, MD, FACG

F. Use of therapeutic endoscopic techniques to manage complications of Crohn's disease
Raymond K. Cross, Jr., MD, MS, Francis A. Farraye, MD, MSc, FACG, Asher Kornbluth, MD, and Bo Shen, MD, FACG

2:45 pm

Case-based sessions end: Participants have 15 minutes to move to new session

3:00 pm

A. Challenging IBD patients with concurrent liver disease: Case studies
Faten N. Aberra, MD, MSCE, David P. Hudesman, MD, Edward V. Loftus, Jr., MD, FACG, and Andrew Tinsley, MD

B. Treatment of complicated ulcerative colitis patients following surgery: Case studies with videos
Willem Bemelman, MD, Paulo G. Kotze, MD, Scott Strong, MD, and Thomas A. Ullman, MD, FACG

C. Managing IBD patients with a prior or current malignancy: Case Studies
Jean H. Ashburn, MD, Meenakshi Bewtra, MD, PhD, MPH, Jason K. Hou, MD, MS, FACG, and Lauren K. Tormey, MD

D. Recognizing and managing side effects due to medications used to treat IBD: Case studies
Anita Afzali, MD, MPH, FACG, Leonard Baidoo, MD, FACG, L. Campbell Levy, MD, and Millie D. Long, MD, MPH, FACG

E. Reassessing immunomodulators: Which patient, which drug, and which dose: Case studies
Ashwin N. Ananthakrishnan, MBBS, MD, MPH, Seymour Katz, MD, MACG, Marc B. Schwartz, MD, and Douglas C. Wolf, MD, FACG

F. Use of therapeutic endoscopic techniques to manage complications of Crohn's disease
Raymond K. Cross, Jr., MD, MS, Francis A. Farraye, MD, MSc, FACG, Asher Kornbluth, MD, and Bo Shen, MD, FACG

3:45 pm

Break

Faten N. Aberra, MD, MSCE
Anita Afzali, MD, MPH, FACG
Ashwin N. Ananthakrishnan, MBBS, MD, MPH
Jean H. Ashburn, MD
Leonard Baidoo, MD, FACG
Willem Bemelman, MD
Meenakshi Bewtra, MD, PhD, MPH
Raymond K. Cross, Jr., MD, MS
Francis A. Farraye, MD, MSc, FACG
Jason K. Hou, MD, MS, FACG
David P. Hudesman, MD
Seymour Katz, MD, MACG
Asher Kornbluth, MD
Paulo G. Kotze, MD
L. Campbell Levy, MD
Edward V. Loftus, Jr., MD, FACG
Millie D. Long, MD, MPH, FACG
Marc B. Schwartz, MD
Bo Shen, MD, FACG
Scott Strong, MD
Andrew Tinsley, MD
Lauren K. Tormey, MD
Thomas A. Ullman, MD, FACG
Douglas C. Wolf, MD, FACG

CLINICAL TRACK
Session XI-A: Progress in IBD Patient Care

Co-Moderators: Ashwin N. Ananthakrishnan, MBBS, MD, MPH and Meenakshi Bewtra, MD, PhD, MPH

4:00 pm

Defining an IBD patient's disease severity and prognosis
Corey A. Siegel, MD, MS

4:20 pm

Therapeutic drug monitoring: When, why, and how
Adam S. Cheifetz, MD, FACG

4:40 pm

Challenges in treating the elderly patient with IBD
Seymour Katz, MD, MACG

5:00 pm

Clostridia difficile in IBD
David G. Binion, MD, FACG

5:20 pm

Panel discussion

5:40 pm

Adjourn

Ashwin N. Ananthakrishnan, MBBS, MD, MPH
Meenakshi Bewtra, MD, PhD, MPH
David G. Binion, MD, FACG
Adam S. Cheifetz, MD, FACG
Seymour Katz, MD, MACG
Corey A. Siegel, MD, MS
43Days
23Hours
0Mins
27Secs

Location

Walt Disney World Dolphin Hotel
1500 Epcot Resorts Boulevard, Lake Buena Vista, Florida 32830
+1-407-934-4000registration@imedex.com

Recent News

Registration Info

Early
USD
PHYSICIANS : $449
PHD & PHARMD : $324
NURSES & PHYSICIAN ASSISTANTS : $175
RESIDENTS/FELLOWS/STUDENTS* : $175
INDUSTRY : $700
Book Now
Discounted
USD
PHYSICIANS : $549
PHD & PHARMD : $424
NURSES & PHYSICIAN ASSISTANTS : $200
RESIDENTS/FELLOWS/STUDENTS* : $200
INDUSTRY : $700
Book Now
Regular
USD
PHYSICIANS : $649
PHD & PHARMD : $524
NURSES & PHYSICIAN ASSISTANTS : $225
RESIDENTS/FELLOWS/STUDENTS* : $225
INDUSTRY : $700
Book Now

Frequently Asked Questions

What is the date/location of the 2017 conference?

This year’s meeting will be held November 9-11 at the Walt Disney World Dolphin Hotel.

How do I get my 2016 CME certificate?

An email with CME request information was sent to the address listed on the back of your badge. If you have not received this email, please contact registration at registration@imedex.com or call us at +1 (800) 233-0957.

How do I get the 2016 slide presentations?

An email with a link to all released presentations has been sent to the address listed on the back of your conference badge, including all notes you may have taken onsite. If you have not received this email, please contact registration at registration@imedex.com or call us at +1 (800) 233-0957.

How do I find a room at the conference hotel?

For the convenience of participants, a room block with a limited number of rooms has been reserved at the discounted conference rate. Please visit the Conference Location and Hotel Accommodations page for more details.

How do I follow the conference on social media?

You can follow the congress Twitter account at @ibdconference using hash tag #AIBD2017 and our Facebook page.

How do I exhibit at AIBD 2017?

Please visit the Exhibitors page for more details on exhibiting at the conference, or contact Stacy Brandau directly:

Stacy S. Brandau
s.brandau@imedex.com
+1 (404) 384-8416

READY FOR A REPLAY?

The webcasts from 2016 are now available. Access them at your convenience, and on your time.

ORGANIZED BY